Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meetingby Susan Leighton, Ovarian Cancer Survivor and Research Advocate Since the first time I attended ASCO I have seen the number of abstracts presented about ovarian cancer increase significantly as understanding of the disease has expanded. No longer do we hear the one size fits … Continued
The Capital Ovarian Cancer Organization (C.O.C.O.) was founded in August of 2007, in memory Debi Furnish, who died from ovarian cancer in 2005. Around the same time, another woman from Frankfort, Ellen Liebman, died from the disease. Debi’s sister, Beverly Van Houten, and her friend, Jerri Robinson, decided they needed to raise awareness of the … Continued
(June 20, 2016) Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meeting by Susan Leighton, Ovarian Cancer Survivor and Research Advocate Since the first time I attended ASCO I have seen the number of abstracts presented about ovarian cancer increase significantly as understanding of the disease has expanded. No longer do we hear … Continued
(June 17, 2016) An OCRFA funded study recently published in Oncogene investigated the role that protein STAT3 plays in the activation and metastasis of ovarian cancer cells. Many women with ovarian cancer develop fluid in the abdomen, which contains cancer cells. Those cells, coupled with a high activation of STAT3, can spread to other areas … Continued
With deep sorrow, Ovarian Cancer Research Alliance mourns the passing of our beloved founder and Chairman Emeritus, Sol Schreiber.
(June 9, 2016) A ten year, OCRFA-funded study has revealed the effect that the human leukocyte antigen (HLA) genes, which help regulate the body’s immune system, have on how the body responds to treatment of epithelial ovarian cancer. The scientists report that women with certain types of HLA may have an increased risk of ovarian … Continued
(June 7, 2016) The Journal of the National Comprehensive Cancer Network recently published a study that looked at the difference in outcomes between two groups of epithelial ovarian cancer patients: those who received recommended, multiagent chemotherapy and those who chose not to undergo the recommended treatment. After tracking thousands of patients in both groups, the … Continued
In August of 2014, Sherry Pollex became a part of this incredible, strong, inspirational and ever beautiful community of ovarian cancer survivors. OCRA first got to know Sherry when she was first diagnosed. We knew right away that Sherry was a special person, when her first question was, “How can I help save other women … Continued
(May 25, 2016) A new study published in the International Journal of Gynecological Cancer earlier this month investigated the impact of body mass index (BMI) on completion, complications, and clinical outcomes of intraperitoneal (IP) chemotherapy in patients with advanced-stage ovarian cancer. The study followed ninety two patients through a minimum of one cycle of IP … Continued
Later this week, we’ll be sending out a request for you to take Action to help protect ovarian cancer research funding at the Department of Defense. The Ovarian Cancer Research Program (OCRP) is part of the Congressionally Directed Medical Research Program in the Department of Defense (DoD), and funds innovative and cutting edge ovarian cancer … Continued
Foodie Fast-Casual Brand Reaches Halfway Point in Its 200-Unit Growth Plan JACKSON, Miss. — Pairing a big moment with a big cause, fast-casual Newk’s Eatery is celebrating its centennial restaurant opening by uniting system-wide to raise $100,000 for ovarian cancer research starting April 4. Each of Newk’s 100 restaurants has committed to raising $1,000, inviting … Continued
When Lori Newcomb first visited her doctor for abdominal pain, the last thing she expected to walk out with was a late-stage ovarian cancer diagnosis. Blindsided and heartbroken by a type of cancer very few recognize or understand, Lori and her husband Chris, Co-founder and CEO of Newk’s Eatery, saw an opportunity to save women’s … Continued
Get email updates about research news, action alerts, and ways to join the fight.
